ArticleInternational journal of laboratory hematology2026
A Retrospective Study of Adult and Pediatric D-Dimer Tests to Identify Opportunities for Improved Utilization.
Article in International journal of laboratory hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Retrospective Study of Adult and Pediatric D-Dimer Tests to Identify Opportunities for Improved Utilization.International journal of laboratory hematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionD-dimers are produced by lysis of cross-linked fibrin. In children, D-dimer testing is used to evaluate disseminated intravascular coagulation (DIC) and some inflammatory states, but its use is not validated for screening or ruling out suspected venous thromboembolic events (VTE). In adults, D-dimers are used to evaluate DIC, and a low D-dimer level is used to exclude VTE in patients when combined with a low or moderate probability of VTE.
methodsTo assess D-dimer utilization and opportunities for improvement, we conducted a retrospective, consecutive-case cohort study (with ethics approval) of patients who had D-dimer tests at Hamilton hospitals, from 06/2022 to 05/2023.
resultsD-dimer levels were evaluated for 175 children and 200 adults (respective results, children/adults: median ages: 12/63, ranges 0-17/18-94 years), and an overlapping cohort of 99 consecutive persons with ≥ 5 D-dimer determinations. Most patients had D-dimer tests in emergency departments (60%/62%) and elevated D-dimer levels (55%/61%). Reasons for D-dimer assessment included: suspected VTE (50%/70%), DIC (17%/3.5%), childhood inflammatory conditions (23%/0%), and "off-label" uses (e.g., arterial thrombosis assessment; 5%/22%). VTE likelihood and DIC scores were rarely documented. Patients with multiple tests accounted for 15% of D-dimer workload. Among patients with multiple tests for DIC, most had overt DIC on initial assessment, with declining D-dimer levels over 10-14 days, including patients who died.
conclusionVTE and DIC assessment was the most common reason for D-dimer assessments for children and adults. Quality improvement initiatives are needed to improve relevant clinical VTE and DIC score documentation and D-dimer test utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.